Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Characterization of the Novel Positive Allosteric Modulator, LY2119620, at the Muscarinic M2 and M4 Receptors

Carrie H. Croy, Douglas A. Schober, Hongling Xiao, Anne Quets, Arthur Christopoulos and Christian C. Felder
Molecular Pharmacology July 2014, 86 (1) 106-115; DOI: https://doi.org/10.1124/mol.114.091751
Carrie H. Croy
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (C.H.C., D.A.S., H.X., A.Q., C.C.F.); and Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria, Australia (A.C.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglas A. Schober
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (C.H.C., D.A.S., H.X., A.Q., C.C.F.); and Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria, Australia (A.C.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hongling Xiao
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (C.H.C., D.A.S., H.X., A.Q., C.C.F.); and Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria, Australia (A.C.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne Quets
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (C.H.C., D.A.S., H.X., A.Q., C.C.F.); and Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria, Australia (A.C.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arthur Christopoulos
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (C.H.C., D.A.S., H.X., A.Q., C.C.F.); and Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria, Australia (A.C.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian C. Felder
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (C.H.C., D.A.S., H.X., A.Q., C.C.F.); and Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria, Australia (A.C.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 86 no. 1 106-115
DOI 
https://doi.org/10.1124/mol.114.091751
PubMed 
24807965

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received January 10, 2014
  • Accepted May 7, 2014
  • Published online June 3, 2014.

Article Versions

  • Earlier version (May 7, 2014 - 10:29).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Carrie H. Croy,
  2. Douglas A. Schober,
  3. Hongling Xiao,
  4. Anne Quets,
  5. Arthur Christopoulos, and
  6. Christian C. Felder
  1. Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (C.H.C., D.A.S., H.X., A.Q., C.C.F.); and Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria, Australia (A.C.)
  1. Address correspondence to:
    Dr. Christian C. Felder, Eli Lilly and Company, Lilly Corporate Center Drop 0510, Indianapolis, IN 46285. E-mail: felder{at}lilly.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: May 2014 to January 2023

AbstractFullPdf
May 20142917129
Jun 201437056100
Jul 20141113850
Aug 2014722631
Sep 2014482221
Oct 2014583642
Nov 20141392318
Dec 2014321621
Jan 2015351721
Feb 2015191913
Mar 2015401414
Apr 2015231520
May 2015141414
Jun 2015301723
Jul 2015312721
Aug 2015241613
Sep 2015242328
Oct 2015111730
Nov 2015131557
Dec 2015142028
Jan 2016202325
Feb 2016271534
Mar 2016202634
Apr 2016172342
May 2016121425
Jun 2016161119
Jul 2016162230
Aug 2016101122
Sep 2016133623
Oct 201602832
Nov 201633430
Dec 201602312
Jan 201702923
Feb 201732222
Mar 201764636
Apr 201721234
May 201714142
Jun 201713038
Jul 201712542
Aug 201722341
Sep 201714346
Oct 2017411326
Nov 201732922
Dec 201742815
Jan 201814331
Feb 201823020
Mar 201813223
Apr 201833026
May 201803429
Jun 201822832
Jul 201822119
Aug 201821527
Sep 201843016
Oct 201832525
Nov 201814224
Dec 201811719
Jan 201922632
Feb 201912522
Mar 201922934
Apr 201902725
May 201922232
Jun 201939511
Jul 20193848
Aug 201943519
Sep 201936418
Oct 201934720
Nov 201937918
Dec 2019191415
Jan 202002328
Feb 202022829
Mar 202016336
Apr 202003735
May 202002849
Jun 202048831
Jul 2020551021
Aug 202044313
Sep 202037312
Oct 202030820
Nov 2020421115
Dec 202027211
Jan 2021621217
Feb 2021812141
Mar 202142312
Apr 20211656
May 20212788
Jun 20211735
Jul 20212179
Aug 202132716
Sep 2021441215
Oct 20212454
Nov 202122410
Dec 20212555
Jan 202242716
Feb 20222172
Mar 20221423
Apr 20223244
May 202235712
Jun 20223346
Jul 202238510
Aug 202235714
Sep 20223255
Oct 202250512
Nov 20223186
Dec 20222024
Jan 20234444

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 86 (1)
Molecular Pharmacology
Vol. 86, Issue 1
1 Jul 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Characterization of the Novel Positive Allosteric Modulator, LY2119620, at the Muscarinic M2 and M4 Receptors
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

M2/M4 Receptor Modulation by LY2119620, ACh, Oxo, and Iperoxo

Carrie H. Croy, Douglas A. Schober, Hongling Xiao, Anne Quets, Arthur Christopoulos and Christian C. Felder
Molecular Pharmacology July 1, 2014, 86 (1) 106-115; DOI: https://doi.org/10.1124/mol.114.091751

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

M2/M4 Receptor Modulation by LY2119620, ACh, Oxo, and Iperoxo

Carrie H. Croy, Douglas A. Schober, Hongling Xiao, Anne Quets, Arthur Christopoulos and Christian C. Felder
Molecular Pharmacology July 1, 2014, 86 (1) 106-115; DOI: https://doi.org/10.1124/mol.114.091751
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Fatty acid amide hydrolase in cisplatin nephrotoxicity
  • eCB Signaling System in hiPSC-Derived Neuronal Cultures
  • Benzbromarone relaxes airway smooth muscle via BK activation
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics